Clinical Trial Update: Effects of Dynorphin 1-13 on Heroin Addiction - 1 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing dynorphin 1-13 for heroin addiction; the study conducted at the University of Minnesota has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Opioid Withdrawal

Drugs mentioned

• Dynorphin 1-13 (Dynorphin 1-13)

Snippet

Sponsor: University of Minnesota | Conditions: Opioid-Related Disorders, Substance Withdrawal Syndrome | Phase 2 | Status: COMPLETED